Trump’s reclassification move on marijuana could boost medical research – C&EN
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic ResearchPolicySchedule IClinical…
Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
The temporary scheduling of 2-fluorodeschloroketamine reflects regulatory efforts to control emerging synthetic ketamine analogs. This DEA action addresses public health concerns related to novel psychoactive substances. Clinicians should stay informed…
Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act
✦ New CED Clinical Relevance #70 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Policy Watch | Federal Register PolicySafetyMental Health Clinical Summary The Drug Enforcement…
